Verify benefit and prior authorization requirements

Coverage for cognitive rehabilitation may be subject to the terms, conditions and limitations of the applicable benefit plan's Short Term Rehabilitative Therapy benefit and schedule of copayments; providers should refer to the customer's benefit plan for any prior authorization requirements before initiating services.

• When billing, use the most appropriate codes as of the date of submission; claims submitted without covered code(s) under this policy will be denied as not covered.

Confirm diagnosis matches listed ICD‑10 codes

Coverage is contingent on meeting the policy's criteria and is linked to the enumerated ICD‑10 diagnosis codes for traumatic intracranial injury and related sequelae (including Z87.820). Providers should confirm the member's diagnosis is one of the listed codes when requesting authorization or submitting claims.

• Policy lists numerous S06.* sequela codes and Z87.820 (Personal history of traumatic brain injury).
• Services with diagnosis codes not specifically listed are considered Not Medically Necessary and may be denied.

Prior review recommended for multidisciplinary programs

Multidisciplinary or intensive programs should undergo prior review; programs must define the specific intervention components and justify the intensity and timing relative to injury severity to support medical necessity.

• Evidence reviews note that multidisciplinary postacute rehabilitation studies often do not define program components clearly; lack of definition may prompt prior review.

Document modality and targeted impairment on authorization requests

When requesting prior authorization, explicitly describe the planned CR modality and the targeted impairment(s) and cite supporting evidence strength (e.g., computer-assisted training or VR for post‑stroke cognitive impairment where meta-analyses exist).

• Indicate modality (individual/group/computerized/VR), targeted cognitive domain, and linkage to evidence when applicable.

Include diagnosis, goals, modality, frequency/duration in prior authorization

Prior authorization requests should identify the diagnosis, individualized, measurable treatment goals, the planned CR modality (individual, group, computerized), frequency and duration, and baseline functional measures used to justify medical necessity.

• CR trials commonly specify goal‑oriented plans and session counts (e.g., 10 weekly sessions plus maintenance) and measure goal attainment to support continuation.

Seek prior authorization for established indications with documentation

Obtain prior authorization when coverage depends on demonstrating the condition and that CR is being applied for established indications (e.g., moderate–severe TBI or stroke with documented deficits); provide evidence that the indication matches those with supportive literature.

• The policy supports CR for moderate/severe TBI and selected stroke deficits when part of a comprehensive, goal‑directed program; evidence is insufficient for many other diagnoses.

References do not add prior authorization requirements

The policy's references section does not specify additional prior authorization rules beyond plan and policy criteria; use the applicable benefit plan document for any further authorization requirements.

• References list bibliographic sources but do not state extra prior authorization requirements.

No step therapy specified in policy

No step therapy requirements are specified in this policy; there are no defined mandatory conservative-to-intensive sequences required by the document.

• The document explicitly states no step therapy requirements are specified in this section.

Step from education to intensive rehabilitation for mild TBI

For mild brain injury, provide education/information first and reserve intensive rehabilitation for moderate‑to‑severe injury; document rationale if requesting more intensive services for mild injury.

• SIGN guidance recommends reassurance and conservative management for mild TBI, with intensive services reserved for higher severity or persistent deficits.

Assess and address contributing factors; favor metacognitive strategies

Address contributing factors (hearing, vision, sleep, mood, substance use, medications) and consider metacognitive strategy training alongside or prior to drill‑based computer tasks when clinically appropriate.

• Ponsford et al. (2023) recommends screening for and addressing factors contributing to attention problems and endorses metacognitive strategy training focused on everyday activities.

Consider multimodal or combined cognitive interventions

Consider combined or multimodal cognitive interventions (e.g., CR plus other nonpharmacologic modalities) when evidence supports greater effectiveness than CR alone; document the multimodal approach and supporting rationale.

• Reviews note combined interventions may show superior efficacy in some analyses and recommend considering multimodal approaches where appropriate.

No defined step therapy protocols in policy

No specific step therapy protocols are defined in this document; clinical judgment and available evidence should guide sequencing of services.

• The policy emphasizes limited evidence for several conditions and does not prescribe required stepwise treatment algorithms.

Provide documentation demonstrating individualized medical necessity

Document an individualized program demonstrating cognitive impairment with related compromised functional status, neuropsychological testing or appropriate assessments used for treatment planning, the patient's ability and willingness to participate, and an expectation of significant cognitive and functional improvement.

• Policy requires comprehensive neuropsychological testing prior to initiation and that treatment be structured, systematic, goal‑directed and individualized.
• Residential placement requires documentation that 24‑hour supervision is necessary due to severe impairments.

Obtain and include baseline neuropsychological testing and goals

Prior to initiation, document comprehensive neuropsychological testing or appropriate assessment identifying baseline deficits and measurable goals; show structured, goal‑directed individualized treatment and measurable outcomes with expectation of some improvement within two weeks.

• The policy states an expectation that some improvement can be demonstrated through documentation within two weeks.
• Neuropsychological testing should be used to direct the treatment plan and develop measurable goals.

Document deficits and functional goals tied to everyday function

Assess and document specific cognitive deficits (attention, visual neglect, memory, executive function) and clearly link functional goals to everyday activities the intervention will target.

• Assessment and documentation should focus on cognitive deficits and functional goals showing how interventions target everyday activities, per guideline recommendations.

Record trial protocol details and measure goal attainment

Include trial protocols in documentation (e.g., goal‑oriented plans with session counts such as 10 weekly sessions plus maintenance) and measures of goal attainment and functional outcomes to support medical necessity and continuation.

• Dementia RCTs described used 10 weekly sessions plus maintenance and measured participant goal attainment as primary outcomes to demonstrate benefit.

Measure and document individualized goals and goal attainment

Document individualized, goal‑oriented CR interventions and measured goal attainment (for example COPM or similar goal attainment scaling) to demonstrate observed benefits in everyday functioning.

• High‑certainty RCT evidence in dementia shows large positive effects on participant‑rated goal attainment when CR is individualized and goal‑oriented.

Document diagnosis, objective impairment measures, and CR modality

Providers should document the diagnosis, objective cognitive impairment (e.g., impaired processing speed on SDMT in MS trials), and the specific cognitive rehabilitation modality used, since trial inclusion criteria and outcomes are modality‑dependent.

• CogEx trial required impaired SDMT performance for inclusion and used an individualized, computer‑based approach; other condition‑specific trials specify modality and inclusion measures.

References do not impose additional documentation requirements

The references section lists bibliographic sources but does not add further provider documentation requirements; rely on the policy and applicable benefit plan for documentation standards.

• References provide supporting literature but do not specify additional documentation obligations.

Ensure claims use covered procedure codes

Claims submitted for services that are not accompanied by covered code(s) under this policy will be denied as not covered; ensure use of CPT 97129/97130 when services meet policy criteria.

• When billing, providers must use the most appropriate codes; absence of covered codes on a claim leads to denial.

Avoid billing for diagnoses not listed as medically necessary

Services with ICD‑10‑CM diagnosis codes other than the enumerated trauma/stroke codes are considered Not Medically Necessary and may be denied; verify that the member's diagnosis is among the listed codes before submitting claims or authorization requests.

• Policy states 'All other codes' are Not Medically Necessary for cognitive rehabilitation.

Do not submit claims for coma stimulation (S9056)

Do not bill for coma stimulation (HCPCS S9056); this service is classified as Experimental/Investigational/Unproven and is excluded from coverage and may be denied.

• HCPCS code S9056 (Coma stimulation per diem) is listed as Experimental/Investigational/Unproven.

Evidence gaps may trigger denial without individualized justification

Interventions lacking robust evidence or used for conditions with insufficient supporting data (for example mild TBI or some post‑stroke applications) may be vulnerable to denial unless individualized evidence of functional need is documented.

• Cochrane and AHRQ reviews note insufficient high‑quality evidence for persisting functional benefit in many areas; lack of documented functional need increases denial risk.

Risk of denial for interventions lacking evidence of persistent functional benefit

Interventions without sufficient high‑quality evidence of persistent functional benefit (for example many cognitive rehabilitation approaches after stroke or neglect) may be at risk for denial when used to claim sustained functional improvement.

• Meta-analyses found short‑term test improvements but insufficient evidence of persistent functional benefits for attention and neglect interventions.

Effectiveness‑based denial risk if expected outcomes are not met

Interventions that do not demonstrate clinically meaningful improvements in targeted outcomes (e.g., processing speed in progressive MS as tested in CogEx) may not meet effectiveness expectations for continued coverage.

• CogEx randomized trial found combined cognitive rehabilitation plus exercise did not improve processing speed in progressive MS, indicating effectiveness‑based denial risk when outcomes are not met.

Limited evidence for coverage outside TBI and stroke

Use of cognitive rehabilitation for diagnoses other than moderate to severe TBI or stroke/cerebral infarction is not established by the literature and may not meet coverage criteria; document strong justification and functional need if treating other conditions.

• Policy states the role of CR for conditions outside TBI or stroke has not been established and the evidence is insufficient for routine coverage.

References do not contain denial criteria

No denial criteria are present in the reference sections themselves; denial risks derive from policy coverage criteria, coding, and evidence limitations documented elsewhere in the policy.

• References do not list specific denial conditions.